Melanie Eggers is a Sterilisation Validation Project Support Engineer at Pfizer Belgium. In this webinar, she explains how Pfizer has adopted Enzyme Indicator (EI) technology for its VHP bio-decontamination procedures.
She outlines the differences in EIs compared to more traditional Biological Indicators and the way in which Pfizer utilises the technology. Melanie also explores how the detailed data EIs provide assist with cycle development, requalification, investigations and validation.
Find out how by integrating Enzyme Indicators into their bio-decontamination validation cycle, Pfizer achieved the following:
- Speeds up investigations and cycle development timelines
- Improves cycle efficacy and lowers decontamination cycle times
- Hidden cost benefit in terms of getting through validation process
Watch this 3 minute or complete the form below for the full video.
Please complete the form below to receive access to the full Video.